Answers are grounded in this paper and cite their sources.
Factor inhibiting HIF (FIH) is a key oxygen‐sensing signaling enzyme that senses changes in oxygen concentration and regulates the expression of hypoxia‐inducible factor (HIF). It is also an important target for the development of drugs against hypoxia‐related diseases. In this study, a capillary electrophoresis method combining micellar electrokinetic chromatography with laser‐induced fluorescence detection (MEKC‐LIF) was established. This method enables direct separation and detection of the fluorescently labeled substrate peptide and its hydroxylated products catalyzed by FIH. Under optimized conditions, the intra‐day RSD for peak area and for apparent electrophoretic mobility of the substrate peptide were 2.08% and 1.56%, respectively. The inter‐day RSD were 3.81% and 4.34%, respectively. The LOD and LOQ were 0.07 and 0.24 µM, with recovery rates ranging from 82.83% to 107.86%. The feasibility and accuracy of this method for screening FIH inhibitors were verified using 4‐nitrocatechol, a known model inhibitor. The IC 50 and inhibition type obtained were consistent with literature reports. It was then applied to screen 15 natural products. Salvianolic acid A and isochlorogenic acid A were found to exhibit potent FIH inhibitory activity. This method overcomes the difficulty of separating structurally similar substrates and products in FIH activity assays. It also provides technical support for discovering potential drug molecules targeting hypoxia‐related diseases via the HIF–FIH oxygen‐sensing pathway.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: